These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29334118)

  • 1. Markers of proliferation and invasiveness in somatotropinomas.
    Baldys-Waligorska A; Wierzbicka I; Sokolowski G; Adamek D; Golkowski F
    Endokrynol Pol; 2018; 69(2):182-189. PubMed ID: 29334118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53.
    Kasuki Jomori de Pinho L; Vieira Neto L; Armondi Wildemberg LE; Gasparetto EL; Marcondes J; de Almeida Nunes B; Takiya CM; Gadelha MR
    Neuroendocrinology; 2011; 94(1):39-48. PubMed ID: 21178332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.
    Jaffrain-Rea ML; Rotondi S; Turchi A; Occhi G; Barlier A; Peverelli E; Rostomyan L; Defilles C; Angelini M; Oliva MA; Ceccato F; Maiorani O; Daly AF; Esposito V; Buttarelli F; Figarella-Branger D; Giangaspero F; Spada A; Scaroni C; Alesse E; Beckers A
    Endocr Relat Cancer; 2013 Oct; 20(5):753-66. PubMed ID: 23940012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of AIP and inhibitory G protein alpha 2 proteins on clinical features of sporadic GH-secreting pituitary adenomas.
    Ritvonen E; Pitkänen E; Karppinen A; Vehkavaara S; Demir H; Paetau A; Schalin-Jäntti C; Karhu A
    Eur J Endocrinol; 2017 Feb; 176(2):243-252. PubMed ID: 27998919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells.
    Rotondi S; Modarelli A; Oliva MA; Rostomyan L; Sanita P; Ventura L; Daly AF; Esposito V; Angelucci A; Arcella A; Giangaspero F; Beckers A; Jaffrain-Rea ML
    Mol Cell Endocrinol; 2016 May; 426():61-72. PubMed ID: 26872613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
    Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E
    Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion.
    Cai F; Hong Y; Xu J; Wu Q; Reis C; Yan W; Wang W; Zhang J
    World Neurosurg; 2019 Mar; 123():e45-e59. PubMed ID: 30447469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cavernous sinus invasion and effect of immunohistochemical features on remission in growth hormone secreting pituitary adenomas.
    Yilmaz M; Vural E; Koc K; Ceylan S
    Turk Neurosurg; 2015; 25(3):380-8. PubMed ID: 26037177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p53 and selected proliferative markers (Ki-67, MCM3, PCNA, and topoisomerase IIα) in borderline ovarian tumors: Correlation with clinicopathological features.
    Ciepliński K; Jóźwik M; Semczuk-Sikora A; Gogacz M; Lewkowicz D; Ignatov A; Semczuk A
    Histol Histopathol; 2018 Feb; 33(2):171-179. PubMed ID: 28493257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
    Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
    Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space.
    Pan LX; Chen ZP; Liu YS; Zhao JH
    J Neurooncol; 2005 Aug; 74(1):71-6. PubMed ID: 16078111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas.
    Foltran RK; Amorim PVGH; Duarte FH; Grande IPP; Freire ACTB; Frassetto FP; Dettoni JB; Alves VA; Castro I; Trarbach EB; Bronstein MD; Jallad RS
    Braz J Med Biol Res; 2018 Jun; 51(9):e7427. PubMed ID: 29947650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Ki-67, p53 and vascular endothelial growth factor (VEGF) concomitantly in growth hormone-secreting pituitary adenomas; which one has a role in tumor behavior ?
    Yarman S; Kurtulmus N; Canbolat A; Bayindir C; Bilgic B; Ince N
    Neuro Endocrinol Lett; 2010; 31(6):823-8. PubMed ID: 21196926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase IIα as a prognostic factor in pituitary tumors.
    Trofimiuk-Müldner M; Bałdys-Waligórska A; Sokołowski G; Adamek D; Hubalewska-Dydejczyk A; Gołkowski F
    Pol Arch Med Wewn; 2014; 124(10):500-8. PubMed ID: 25692206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas.
    Fusco A; Zatelli MC; Bianchi A; Cimino V; Tilaro L; Veltri F; Angelini F; Lauriola L; Vellone V; Doglietto F; Ambrosio MR; Maira G; Giustina A; degli Uberti EC; Pontecorvi A; De Marinis L
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2746-50. PubMed ID: 18460561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of DNA topoisomerase type II alpha and Ki-67 in adenoid cystic carcinoma and pleomorphic adenoma of the salivary gland.
    Hirabayashi S
    J Oral Pathol Med; 1999 Mar; 28(3):131-6. PubMed ID: 10069542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas.
    Dénes J; Kasuki L; Trivellin G; Colli LM; Takiya CM; Stiles CE; Barry S; de Castro M; Gadelha MR; Korbonits M
    PLoS One; 2015; 10(2):e0117107. PubMed ID: 25658813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTTG and Ki-67 expression in pituitary adenomas.
    Wierzbicka-Tutka I; Sokołowski G; Bałdys-Waligórska A; Adamek D; Radwańska E; Gołkowski F
    Przegl Lek; 2016; 73(2):53-8. PubMed ID: 27197423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues.
    Oriola J; Lucas T; Halperin I; Mora M; Perales MJ; Alvarez-Escolá C; Paz de MN; Díaz Soto G; Salinas I; Julián MT; Olaizola I; Bernabeu I; Marazuela M; Puig-Domingo M
    Eur J Endocrinol; 2013 Jan; 168(1):9-13. PubMed ID: 23038625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.